• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诱导多能干细胞理解黏多糖贮积症。I:神经前体细胞迁移缺陷的证明。

Induced Pluripotent Stem Cells to Understand Mucopolysaccharidosis. I: Demonstration of a Migration Defect in Neural Precursors.

机构信息

Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, CH-1211 Geneva 4, Switzerland.

Department of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, CH-1211 Geneva 4, Switzerland.

出版信息

Cells. 2020 Dec 3;9(12):2593. doi: 10.3390/cells9122593.

DOI:10.3390/cells9122593
PMID:33287330
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7761689/
Abstract

: Mucopolysaccharidosis type I-Hurler (MPS1-H) is a severe genetic lysosomal storage disorder due to loss-of-function mutations in the gene. The subsequent complete deficiency of alpha l-iduronidase enzyme is directly responsible of a progressive accumulation of glycosaminoglycans (GAG) in lysosomes which affects the functions of many tissues. Consequently, MPS1 is characterized by systemic symptoms (multiorgan dysfunction) including respiratory and cardiac dysfunctions, skeletal abnormalities and early fatal neurodegeneration. : To understand mechanisms underlying MPS1 neuropathology, we generated induced pluripotent stem cells (iPSC) from a MPS1-H patient with loss-of-function mutations in both alleles. To avoid variability due to different genetic background of iPSC, we established an isogenic control iPSC line by rescuing IDUA expression by a lentivectoral approach. : Marked differences between MPS1-H and -corrected isogenic controls were observed upon neural differentiation. A scratch assay revealed a strong migration defect of MPS1-H cells. Also, there was a massive impact of deficiency on gene expression (340 genes with an FDR <0.05). : Our results demonstrate a hitherto unknown connection between lysosomal degradation, gene expression and neural motility, which might account at least in part for the phenotype of MPS1-H patients.

摘要

黏多糖贮积症 I-H 型(MPS1-H)是一种严重的遗传性溶酶体贮积症,由于 基因的功能丧失性突变所致。随后,α-L-艾杜糖苷酸酶的完全缺乏直接导致糖胺聚糖(GAG)在溶酶体中进行性积累,从而影响许多组织的功能。因此,MPS1 的特征是全身症状(多器官功能障碍),包括呼吸和心脏功能障碍、骨骼异常和早期致命性神经退行性变。

为了了解 MPS1 神经病理学的机制,我们从一位 MPS1-H 患者中生成了诱导多能干细胞(iPSC),该患者的 基因的两个等位基因均存在功能丧失性突变。为了避免由于 iPSC 的不同遗传背景而导致的变异性,我们通过慢病毒载体方法拯救 IDUA 表达,建立了同基因对照 iPSC 系。

在神经分化过程中,观察到 MPS1-H 和 -校正同基因对照之间存在明显差异。划痕实验显示 MPS1-H 细胞的迁移缺陷明显。此外, 缺乏对基因表达也有巨大影响(FDR<0.05 的基因有 340 个)。

我们的研究结果表明,溶酶体降解、基因表达和神经运动之间存在着迄今未知的联系,这至少可以部分解释 MPS1-H 患者的表型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b17e/7761689/c7a56b6d0617/cells-09-02593-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b17e/7761689/f1f98bc3ece8/cells-09-02593-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b17e/7761689/afd7bff32a46/cells-09-02593-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b17e/7761689/5753e4a6e1f0/cells-09-02593-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b17e/7761689/ed576d26da5d/cells-09-02593-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b17e/7761689/c7a56b6d0617/cells-09-02593-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b17e/7761689/f1f98bc3ece8/cells-09-02593-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b17e/7761689/afd7bff32a46/cells-09-02593-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b17e/7761689/5753e4a6e1f0/cells-09-02593-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b17e/7761689/ed576d26da5d/cells-09-02593-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b17e/7761689/c7a56b6d0617/cells-09-02593-g005.jpg

相似文献

1
Induced Pluripotent Stem Cells to Understand Mucopolysaccharidosis. I: Demonstration of a Migration Defect in Neural Precursors.诱导多能干细胞理解黏多糖贮积症。I:神经前体细胞迁移缺陷的证明。
Cells. 2020 Dec 3;9(12):2593. doi: 10.3390/cells9122593.
2
Patient iPSC-derived neural stem cells exhibit phenotypes in concordance with the clinical severity of mucopolysaccharidosis I.患者诱导多能干细胞衍生的神经干细胞表现出与黏多糖贮积症 I 临床严重程度一致的表型。
Hum Mol Genet. 2018 Oct 15;27(20):3612-3626. doi: 10.1093/hmg/ddy259.
3
Generation of human induced pluripotent stem cell line UNIGEi001-A from a 2-years old patient with Mucopolysaccharidosis type IH disease.从一名患有I型黏多糖贮积症的2岁患者身上生成人诱导多能干细胞系UNIGEi001-A。
Stem Cell Res. 2019 Dec;41:101604. doi: 10.1016/j.scr.2019.101604. Epub 2019 Oct 15.
4
Mapping of IDUA gene variants in Pakistani patients with mucopolysaccharidosis type 1.巴基斯坦1型黏多糖贮积症患者中艾杜糖醛酸酶(IDUA)基因变异的图谱分析
J Pediatr Endocrinol Metab. 2019 Nov 26;32(11):1221-1227. doi: 10.1515/jpem-2019-0188.
5
Gentamicin-mediated suppression of Hurler syndrome stop mutations restores a low level of alpha-L-iduronidase activity and reduces lysosomal glycosaminoglycan accumulation.庆大霉素介导的对Hurler综合征终止突变的抑制作用可恢复低水平的α-L-艾杜糖醛酸酶活性,并减少溶酶体糖胺聚糖的积累。
Hum Mol Genet. 2001 Feb 1;10(3):291-9. doi: 10.1093/hmg/10.3.291.
6
Mutation Analysis of the Gene in Iranian Patients with Mucopolysaccharidosis Type 1: Identification of Four Novel Mutations.伊朗1型黏多糖贮积症患者该基因的突变分析:鉴定出四个新突变
Genet Test Mol Biomarkers. 2019 Aug;23(8):515-522. doi: 10.1089/gtmb.2019.0022. Epub 2019 Jul 12.
7
Generation of a human induced pluripotent stem cell line, BRCi001-A, derived from a patient with mucopolysaccharidosis type I.源自一名I型黏多糖贮积症患者的人诱导多能干细胞系BRCi001-A的产生。
Stem Cell Res. 2019 Apr;36:101406. doi: 10.1016/j.scr.2019.101406. Epub 2019 Feb 12.
8
Long-term nonsense suppression therapy moderates MPS I-H disease progression.长期无义抑制疗法可缓解I-H型黏多糖贮积症的病情进展。
Mol Genet Metab. 2014 Mar;111(3):374-381. doi: 10.1016/j.ymgme.2013.12.007. Epub 2013 Dec 17.
9
Characterization of an MPS I-H knock-in mouse that carries a nonsense mutation analogous to the human IDUA-W402X mutation.一种 MPS I-H 基因敲入小鼠的特征,该小鼠携带一种类似于人类 IDUA-W402X 突变的无义突变。
Mol Genet Metab. 2010 Jan;99(1):62-71. doi: 10.1016/j.ymgme.2009.08.002.
10
The designer aminoglycoside NB84 significantly reduces glycosaminoglycan accumulation associated with MPS I-H in the Idua-W392X mouse.设计的氨基糖苷类 NB84 可显著减少 Idua-W392X 小鼠 MPS I-H 相关的糖胺聚糖积累。
Mol Genet Metab. 2012 Jan;105(1):116-25. doi: 10.1016/j.ymgme.2011.10.005. Epub 2011 Oct 19.

引用本文的文献

1
Induced Pluripotent Stem Cells for the Treatment of Lysosomal Storage Disorders.诱导多能干细胞用于溶酶体贮积症的治疗
J Inherit Metab Dis. 2025 Jul;48(4):e70064. doi: 10.1002/jimd.70064.
2
Unifying biology of neurodegeneration in lysosomal storage diseases.溶酶体贮积病中神经退行性变的统一生物学机制
J Inherit Metab Dis. 2025 Jan;48(1):e12833. doi: 10.1002/jimd.12833.
3
Neurological Disease Modeling Using Pluripotent and Multipotent Stem Cells: A Key Step towards Understanding and Treating Mucopolysaccharidoses.使用多能和多潜能干细胞进行神经疾病建模:迈向理解和治疗黏多糖贮积症的关键一步。

本文引用的文献

1
Generation of human induced pluripotent stem cell line UNIGEi001-A from a 2-years old patient with Mucopolysaccharidosis type IH disease.从一名患有I型黏多糖贮积症的2岁患者身上生成人诱导多能干细胞系UNIGEi001-A。
Stem Cell Res. 2019 Dec;41:101604. doi: 10.1016/j.scr.2019.101604. Epub 2019 Oct 15.
2
Neuronal Migration During Development of the Cerebellum.小脑发育过程中的神经元迁移
Front Cell Neurosci. 2018 Dec 17;12:484. doi: 10.3389/fncel.2018.00484. eCollection 2018.
3
Treatment of brain disease in the mucopolysaccharidoses.
Biomedicines. 2023 Apr 21;11(4):1234. doi: 10.3390/biomedicines11041234.
4
Polymer-based drug delivery systems under investigation for enzyme replacement and other therapies of lysosomal storage disorders.用于酶替代治疗和其他溶酶体贮积症治疗的聚合物药物递送系统。
Adv Drug Deliv Rev. 2023 Jun;197:114683. doi: 10.1016/j.addr.2022.114683. Epub 2023 Jan 16.
黏多糖贮积症的脑部疾病治疗。
Mol Genet Metab. 2017 Dec;122S:25-34. doi: 10.1016/j.ymgme.2017.10.007. Epub 2017 Oct 16.
4
Developmental and behavioral aspects of mucopolysaccharidoses with brain manifestations - Neurological signs and symptoms.黏多糖贮积症伴脑表现的发育和行为方面 - 神经系统体征和症状。
Mol Genet Metab. 2017 Dec;122S:1-7. doi: 10.1016/j.ymgme.2017.08.009. Epub 2017 Aug 26.
5
Early disease progression of Hurler syndrome.黏多糖贮积症Ⅰ型的早期疾病进展
Orphanet J Rare Dis. 2017 Feb 14;12(1):32. doi: 10.1186/s13023-017-0583-7.
6
Manifestation of Huntington's disease pathology in human induced pluripotent stem cell-derived neurons.亨廷顿舞蹈病病理特征在人诱导多能干细胞衍生神经元中的表现。
Mol Neurodegener. 2016 Apr 14;11:27. doi: 10.1186/s13024-016-0092-5.
7
Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells.利用人类诱导多能干细胞(iPS细胞)构建阿尔茨海默病模型。
Mol Cell Neurosci. 2016 Jun;73:13-31. doi: 10.1016/j.mcn.2015.11.010. Epub 2015 Dec 4.
8
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer.器官大小调控、组织稳态及癌症中的河马信号通路
Cell. 2015 Nov 5;163(4):811-28. doi: 10.1016/j.cell.2015.10.044.
9
Neurocognition across the spectrum of mucopolysaccharidosis type I: Age, severity, and treatment.I型黏多糖贮积症全谱系中的神经认知:年龄、严重程度及治疗
Mol Genet Metab. 2015 Sep-Oct;116(1-2):61-8. doi: 10.1016/j.ymgme.2015.06.002. Epub 2015 Jun 17.
10
Heparan sulfate saccharides modify focal adhesions: implication in mucopolysaccharidosis neuropathophysiology.硫酸乙酰肝素糖修饰黏着斑:在黏多糖贮积症神经病理生理学中的意义。
J Mol Biol. 2015 Feb 27;427(4):775-791. doi: 10.1016/j.jmb.2014.09.012. Epub 2014 Sep 28.